Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alimena

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Haematologica|July 1, 1990
[Interferon in the treatment of Philadelphia-positive chronic myeloid leukemia]E Morra, G Alimena, M Lazzarino, et al.
Scandinavian Journal of Haematology|February 1, 1985
A case of Burkitt lymphoma-L3ALL with t(8;14) translocation, developed 10 years after Hodgkin's diseaseF Mandelli, M Martelli, G Cimino, et al.
The EMBO Journal|May 1, 1986
Translocation of c-myc into the immunoglobulin heavy-chain locus in human acute B-cell leukemia. A molecular analysisA Carè, L Cianetti, A Giampaolo, et al.
Blood|August 1, 1988
Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administrationG Alimena, E Morra, M Lazzarino, et al.
Progress in Clinical and Biological Research|January 1, 1990
Persistent suppression of granulo-erythropoietic precursor cells in alpha interferon treated CML patients undergoing autologous stem cell transplantation: in vitro and clinical resultsP De Fabritiis, A Sandrelli, G Meloni, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Interferon alpha-2b as therapy for patients with Ph'-positive chronic myelogenous leukemiaG Alimena, E Morra, M Lazzarino, et al.
Bone Marrow Transplantation|February 1, 1990
Cytogenetic follow-up after allogeneic bone-marrow transplantation for Ph1-positive chronic myelogenous leukemiaG Alimena, M R De Cuia, C Mecucci, et al.
Leukemia Research|January 1, 1986
Standard conditioning regimen and T-depleted donor bone marrow for transplantation in chronic myeloid leukemiaG Papa, W Arcese, F R Mauro, et al.
Haematologica|November 1, 1987
A cytogenetical analysis in patients with secondary hematological disordersA Zaccaria, G Alimena, R Billström, et al.
Bone Marrow Transplantation|October 1, 1990
Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusionF Lo Coco, F Mandelli, D Diverio, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Haematologica|July 1, 1990
[Interferon in the treatment of Philadelphia-positive chronic myeloid leukemia]E Morra, G Alimena, M Lazzarino, et al.
Scandinavian Journal of Haematology|February 1, 1985
A case of Burkitt lymphoma-L3ALL with t(8;14) translocation, developed 10 years after Hodgkin's diseaseF Mandelli, M Martelli, G Cimino, et al.
The EMBO Journal|May 1, 1986
Translocation of c-myc into the immunoglobulin heavy-chain locus in human acute B-cell leukemia. A molecular analysisA Carè, L Cianetti, A Giampaolo, et al.
Blood|August 1, 1988
Interferon alpha-2b as therapy for Ph'-positive chronic myelogenous leukemia: a study of 82 patients treated with intermittent or daily administrationG Alimena, E Morra, M Lazzarino, et al.
Progress in Clinical and Biological Research|January 1, 1990
Persistent suppression of granulo-erythropoietic precursor cells in alpha interferon treated CML patients undergoing autologous stem cell transplantation: in vitro and clinical resultsP De Fabritiis, A Sandrelli, G Meloni, et al.
European Journal of Haematology. Supplementum|January 1, 1990
Interferon alpha-2b as therapy for patients with Ph'-positive chronic myelogenous leukemiaG Alimena, E Morra, M Lazzarino, et al.
Bone Marrow Transplantation|February 1, 1990
Cytogenetic follow-up after allogeneic bone-marrow transplantation for Ph1-positive chronic myelogenous leukemiaG Alimena, M R De Cuia, C Mecucci, et al.
Leukemia Research|January 1, 1986
Standard conditioning regimen and T-depleted donor bone marrow for transplantation in chronic myeloid leukemiaG Papa, W Arcese, F R Mauro, et al.
Haematologica|November 1, 1987
A cytogenetical analysis in patients with secondary hematological disordersA Zaccaria, G Alimena, R Billström, et al.
Bone Marrow Transplantation|October 1, 1990
Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusionF Lo Coco, F Mandelli, D Diverio, et al.
Pageof 14